Target is the improved reconstruction of bone defects by local drug delivery from a bone replacement material. A successful market synthetic bone substitute (easy-graft Â®) serves as a release system. From the Polylaktidanteil of the bone substitute material, local agents are targeted and controlled released. The drug release is physically, chemically and analysed with pharmaceutical methods. The effect and safety of promising drug candidates are validated in a relevant animal model and compared.
